Toxic epidermal necrolysis due to administration of celecoxib (Celebrex)
- PMID: 12425513
Toxic epidermal necrolysis due to administration of celecoxib (Celebrex)
Abstract
A 41-year-old woman was given celecoxib (Celebrex) for the treatment of carpal tunnel syndrome. An erythematous rash developed that progressed to exfoliative dermatitis, and the patient was diagnosed with toxic epidermal necrolysis. After transfer to the burn unit, she was treated with topical mupirocin calcium cream and bismuth tribromophenatein petrolatum gauze dressings. Her wounds healed well. This is the first case report of toxic epidermal necrolysis due to treatment with celecoxib of which we are aware.
Comment in
-
Toxic epidermal necrolysis due to administration of celecoxib (Celebrex).South Med J. 2003 Mar;96(3):320-1. doi: 10.1097/01.SMJ.0000061502.81880.58. South Med J. 2003. PMID: 12659372 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources